Living Rheum
Dedicated to uncovering clinical developments and treatment advancements in the field of rheumatology, Living Rheum delivers expert insights on patient management across a broad spectrum of rheumatic diseases, such as rheumatoid arthritis, lupus, scleroderma, osteoporosis, and more.
Molecular Signals and Early Detection in Psoriatic Arthritis
Living RheumMolecular Signals and Early Detection in Psoriatic Arthritis
Navigating the Modern PsA Treatment Landscape
Living RheumNavigating the Modern PsA Treatment Landscape
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Living RheumRethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living RheumUnderstanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living RheumExploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living RheumCadherin-6 in Focus: Existing Antibodies, Emerging Applications
- advertisement
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
CME/CESpotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
- advertisement
Fibrodysplasia Ossificans Progressiva: Mechanism of Disease
Medical Industry FeatureFibrodysplasia Ossificans Progressiva: Mechanism of Disease
- 01/09/2026
- 01/09/2026
- 01/08/2026
- 01/07/2026
- 01/06/2026
- 01/06/2026





































